A 48-Week, Multicenter, Open-Label, Observational Study...

  • Main
  • 2019 / 4
  • A 48-Week, Multicenter, Open-Label, Observational Study...

A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer’s Disease in Taiwan

Chang, Chiung-Chih, Peng, Giia-Sheun, Lai, Te-Jen, Li, Chien-Hsun, Liu, Ching-Kuan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Advances in Therapy
DOI:
10.1007/s12325-019-00939-0
Date:
April, 2019
File:
PDF, 454 KB
2019
Conversion to is in progress
Conversion to is failed